摘要
甲状腺机能亢进症(甲亢)多见于青年女性,故甲亢合并妊娠及哺乳者甚为多见。外科手术及131I同位素治疗显然在大多数情况下对这些患者并不合适,患者也难以接受。但要确保妊娠期及哺乳期母婴平安和健康,用药物治疗并非易事。认真观察妊娠及哺乳期甲状腺功能指标的变化,并研究不同抗甲状腺药物经胎盘、乳腺的弥散规律,以及结合前瞻性的临床研究资料,可给在这两个时期如何正确应用抗甲状腺药物提供一些参考意见。
] Hyperthyroidism (HT) is frequently seen in young females￡?including those with pregnancy or lactation. Surgery and 131I treatment in most cases are not appropriate and acceptable to those pregnant and lactating patients. Therefore, how to use antithyroid drugs (ATD) turns to be a critical issue in regarding to the health and safety for both mothers and infants. Study on the parameters of thyroid function in pregnancy and lactation, the diffusion regulation via placenta and mammary glands, as well as the prospective clinical observations may bring the reference considerations for ATD administration in these two special stages of females.
出处
《中国处方药》
2005年第6期38-40,共3页
Journal of China Prescription Drug
